CompoAtlas

TRANSIT

Food supplement declared in France, declaration No 2019-9-761

TRANSIT (BIOSENS) is a food supplement declared in France. Status: retrait du marché annoncé pour le 17 June 2028. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).

Brand
BIOSENS
Food business operator placing the product on the market
NATURENVIE
Status
Retrait du marché annoncé pour le 17 June 2028
Form
Gélule
Daily dose
2 gélules
Directions for use
2 gélules par jour à avaler avec un verre d'eau
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous anticoagulants, Sous traitement médicamenteux, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Transit

Declaration 165657, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Rheum officinale Baill.RacineExtrait sec hydroalcoolique500 mg
Tamarindus indica L.Fruit (pulpe)Extrait sec aqueux80 mg
Fucus vesiculosus L.ThallePoudre (de plantes séchées ou broyées)60 mg

Other ingredients

Adansonia digitata L.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : BIOSENS

Enter to analyse, Shift+Enter for a new line